A 12q13 translocation involving the HMGI-C gene in Richter transformation of a chronic lymphocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 119, Issue 1, 2000, Pages 70-73

  Santulli, Basilia ^a   Kazmierczak, Bernd ^b   Napolitano, Raffaela ^a   Caliendo, Irene ^a   Chiappetta, Gennaro ^c   Rippe, Volkhard ^b   Bullerdiek, Jörn ^b   Fusco, Alfredo ^d  

^a S G MOSCATI HOSPITAL   (Italy)

^b UNIVERSITY OF BREMEN   (Germany)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Dipto Med Sperim Clin Univ C   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 12; CHRONIC LYMPHATIC LEUKEMIA; COSMID; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRON; LEUKEMOGENESIS; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HIGH MOBILITY GROUP PROTEINS; HMGA2 PROTEIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGED; NEOPLASM PROTEINS; TRANSLOCATION, GENETIC;

EID: 0034058123     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00205-8     Document Type: Article

References (18)

1. Grosschedl R., Giese K., Pagel J. HMG domain proteins. architectural elements in the assembly of nucleoprotein structures Trends Genet. 10:1994;94-100.
2. Lovell-Badge R. Developmental genetics. living with bad architecture Nature (Lond). 376:1995;725-726.
3. Giancotti V., Berlingieri M.T., Di Fiore P.P., Fusco A., Vecchio G., Crane-Robinson C. Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus. Cancer Res. 45:1985;6051-6057.
4. Giancotti V., Pani B., D'Andrea P., Berlingieri M.T., Di Fiore P.P., Fusco A., Vecchio G., Philip R., Crane-Robinson C., Nicolas R.H., Wright C.A., Goodwin G.H. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J. 6:1987;1981-1987.
5. Bussemakers M.J.G., Van de Ven W.J.M., Debruyne F.M.J., Schalken J. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res. 51:1991;606-611.
6. Chiappetta G., Bandiera A., Berlingieri M.T., Visconti R., Manfioletti G., Battista S., Martinez-Tello F.J., Santoro M., Giancotti V., Fusco A. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene. 10:1995;1307-1314.
7. Fedele M., Bandiera A., Chiappetta G., Battista S., Viglietto G., Manfioletti G., Casamassimi A., Santoro M., Giancotti V., Fusco A. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 56:1996;1896-1901.
8. Chiappetta G., Tallini G., De Biasio M.C., Manfioletti G., Martinez-Tello F.J., Pentimalli F., de Nigris F., Mastro A., Botti G., Fedele M., Berger N., Santoro M., Giancotti V., Fusco A. Detection of high mobility group I HMGI(Y) proteins in the diagnosis of thyroid tumors. HMGI(Y) expression represents a potential diagnostic indicator of carcinoma Cancer Res. 58:1998;4193-4198.
9. Bandiera A., Bonifacio D., Manfioletti G., Mantovani F., Rustighi A., Zanconati F., Fusco A., Bonito L.D., Giancotti V. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58:1998;426-431.
10. Berlingieri M.T., Manfioletti G., Santoro M., Bandiera A., Visconti R., Giancotti V., Fusco A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol. 15:1995;1545-1553.
11. Ashar H.R., Schoenberg Fejzo M., Tkachenko A., Zhou X., Fletcher J.A., Weremowicz S., Morton C.C., Chada K. Disruption of the architectural factor HMCI-C. DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains Cell. 82:1995;57-65.
12. Schoenmakers E.F.P.M., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., Van de Ven W.J.M. Recurrent rearrangements in the high mobility group gene HMGI-C, in benign mesenchymal tumors. Nat Genet. 10:1995;436-443.
13. Fedele M., Berlingieri M.T., Scala S., Chiariotti L., Viglietto G., Rippel V., Bullerdiek J., Santoro M., Fusco A. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene. 17:1998;413-418.
14. Seyger M.M.B., Ritterbach J., Creutzig U., Gnekow A.K., Gobel U., Graf N., Reiter A., Lampert F., Harbott J. 12q13, a new recurrent breakpoint in acute nonlymphoblastic leukemia. Cancer Genet Cytogenet. 80:1995;23-28.
15. Brynes R.K., McCourty A., Sun N.C.J., Koo C.H. Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia. Am J Clin Pathol. 104:1995;199-203.
16. Dierlamm J., Wlodarska I., Michaux L., Vermeesch J.R., Meeus P., Stul M., Criel A., Verhoef G., Thomas J., Delannoy A., Louwagie A., Cassiman J.J., Meucci C., Hagemeijer A., Van den Berghe H. FISH identifies different types of duplication with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies charcterized by partial trisomy 12. Genes Chromosom Cancer. 20:1997;155-166.
17. Wanschura S., Hennig Y., Deichert U., Schoenmakers E.F.P.M., Van de Ven W.J.M., Bartnitzke Bullerdiek J. Molecular-cytogenetic refinement of the 12q14-15 breakpoint region affected in uterine leiomyomas. Cytogenet Cell Genet. 71:1995;131-135.
18. Kottickal L.V., Sarada B., Ashar H., Chada K., Nagarajan L. Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia. Biochem Biophys Res Commun. 242:1998;452-456.